Nir Menachemi, Ph.D., M.P.H. is Professor, Fairbanks Endowed Chair, and serves as Chair of the Health Policy and Management department of the Indiana University (IU) Richard M. Fairbanks School of Public Health. He is also a scientist at the Regenstrief Institute, and teaches courses in the physician MBA program at the IU Kelley School of Business in Indianapolis. 

Dr. Menachemi’s research examines how organizational strategies and societal policies impact health and health care outcomes. As such, he works closely with health system and public health decision-makers. Since the start of the pandemic, he has served as principal investigator on the first and largest statewide random sample testing study that has generated breakthrough new knowledge about Covid-19 and garnered national, and international media attention. His team’s work led to an understanding of the asymptomatic rate of SARS-CoV-2 infection, quantified the age-specific risk of death given infection, improved the precision of hospital surge prediction models, and provided strong evidence that influenced pandemic-related policy in Indiana and beyond. His team included a multi-disciplinary group of epidemiologists, biostatisticians, public health, and infection disease experts.

Dr. Menachemi has published more than 250 peer-reviewed scientific papers, and his work regularly appears prestigious professional journals and is covered by the media. He earned a bachelors and master degree from the University at Albany, State University of New York and a PhD in Health Services Administration from the University of Alabama at Birmingham.